The effect of short-chain fatty acids on the susceptibility of human umbilical vein endothelial cells to human cytomegalovirus infection.
We have compared the replication of three strains of human cytomegalovirus (HCMV), HCMV AD-169, HCMV Towne, or HCMV RC-256, an insertional mutant of Towne containing the LacZ gene of E. coli, in human umbilical vein endothelial cells (HUVEC) and human forskin fibroblasts (HFF). We also examine the effects of salts of short-chain fatty acids on the susceptibility of HUVEC to infection by HCMV. All three virus strains replicated in both cell types, but 10-to 100-fold less virus was produced in HUVEC cells than HFF. For all virus strains, expression of HCMV IE-1 antigen in HFF was > 70% 24 h after inoculation. In contrast, the number of HUVEC exhibiting IE-1 antigen at 24 h was < 15%. Treatment of HUVEC with sodium butyrate, sodium hexanoate, or sodium propionate prior to virus inoculation increased the IE-1 and late HCMV antigen expression in a dose- and time-dependent manner. Virus yield was also increased. This increased susceptibility was inhibited by cycloheximide and tunicamycin, indicating a requirement for new cellular protein synthesis. Treatment with both sodium hexanoate and propionate after virus inoculation increased HUVEC susceptibility to HCMV infection. Treatment of HUVEC with sodium butyrate after virus inoculation also increased HCMV IE-1 antigen expression, but only after removal of the drug. These studies demonstrate that the susceptibility of HUVEC to HCMV infection can be increased by the treatment of the host cell with salts of short-chain fatty acids, such as sodium butyrate, before or after virus inoculation.
Wu
Q H
QH
Department of Medicine, University of Connecticut Health Center, Farmington 06030.
Ascensao
J
J
Almeida
G
G
Forman
S J
SJ
Shanley
J D
JD
D000956:Antigens, Viral / Q000032:analysis; D002478:Cells, Cultured; D003587:Cytomegalovirus / Q000187:drug effects / Q000254:growth & development* / Q000378:metabolism / Q000502:physiology; D003586:Cytomegalovirus Infections / Q000276:immunology*; D004198:Disease Susceptibility; D004730:Endothelium, Vascular / Q000166:cytology / Q000187:drug effects / Q000382:microbiology*; D005232:Fatty Acids, Volatile / Q000494:pharmacology*; D005347:Fibroblasts / Q000187:drug effects / Q000382:microbiology*; D006801:Humans; D013045:Species Specificity; D013997:Time Factors; D014471:Umbilical Veins; D014779:Virus Replication / Q000187:drug effects
D000956:Antigens, Viral; D005232:Fatty Acids, Volatile